Consensus Macro Group Pharmaceuticals (Macro Capital) S.A.E
Stocks
MCRO
EGS7D971C011
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
29/09/2026
|
5-day change | 1st Jan Change | ||
| 1.480 EGP | +1.37% |
|
-8.64% | +29.82% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 05-16 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Evolution of the Average Target: Macro Group Pharmaceuticals (Macro Capital) S.A.E
Evolution of the Target Price: Macro Group Pharmaceuticals (Macro Capital) S.A.E
Changes in Analyst Recommendations: Macro Group Pharmaceuticals (Macro Capital) S.A.E
ceabb4780a582ddb5f9940dd41ae.O_SRJEciPBqF-slwn_8h7SrnGAtyLYWmSq1Bs1jL8bI.fY7EFyNOS123u_oX9rdrwBmeV3NFVPPWE-Mg9D-su-FvkqFCIU1WdemgjA~0d6312a7b9a48463427f9f63ee3945cb
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | - | +7.53% | ||||
| +12.16% | ||||||
| +2.19% | ||||||
| +4.63% | ||||||
| +5.61% | ||||||
| +4.42% | ||||||
| +27.66% | ||||||
| -6.91% | ||||||
| +4.23% | ||||||
| +21.93% | ||||||
| Average | +8.35% | |||||
| Weighted average by Cap. | +8.14% |


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.480EGP
Average target price
1.570EGP
Spread / Average Target
+6.08%
High Price Target
1.570EGP
Spread / Highest target
+6.08%
Low Price Target
1.570EGP
Spread / Lowest Target
+6.08%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- MCRO Stock
- Consensus Macro Group Pharmaceuticals (Macro Capital) S.A.E
Select your edition
All financial news and data tailored to specific country editions
















